Data & APIsEventsMarketfyPremarketBoost
Contribute Login Join
Data & APIs
Events
Marketfy
Premarket
Boost

Carlos Trujillo's Net Worth

-$990 Thousand

Estimate Recalculated Sep 8, 2024 07:35PM EST

Who is Carlos Trujillo?

Carlos Trujillo does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include China Tel Group Inc, and PharmaCyte Biotech, Inc..

SEC CIK

Carlos Trujillo's CIK is 0001464520

Past Insider Trading and Trends

2012 was Carlos Trujillo's most active year for acquiring shares with 9 total transactions. Carlos Trujillo's most active month to acquire stocks was the month of June. 2012 was Carlos Trujillo's most active year for disposing of shares, totalling 30 transactions. Carlos Trujillo's most active month to dispose stocks was the month of May. 2009 saw Carlos Trujillo paying a total of $1,106,512.00 for 1,383,140 shares, this is the most they've acquired in one year. In 2009 Carlos Trujillo cashed out on 883,153 shares for a total of $706,522.40, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

China Tel Group Inc No price found

Chief Financial Officer

Carlos Trujillo owns 499,987 units of Common Stock, 4,392,593 units of Series A Common Stock, 857,567 units of Common Stock A and 145,220,606 units of Series B Common Stock. In the year 2009 Carlos Trujillo filed a total of 28 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+65,728.04%
145M
—
$145,000.00
145.22M
Apr 15, 2014
Aug 30 - Mar 24
Form 4
-50.00%
-220.61K
—
-$220.61
220.61K
Apr 8, 2013
Jan 14
Form 4
-3.21%
-145.79K
$0.08
-$11,373.88
4.39M
Dec 28, 2012
Dec 10 - Dec 13
Form 4
+3,008.97%
4.39M
$0.03
$133,968.54
4.54M
Nov 27, 2012
Nov 21
Form 4
-21.55%
-40.10K
$0.03
-$1,182.97
145.98K
Oct 9, 2012
Oct 4 - Oct 5
Form 4
-28.89%
-75.59K
$0.03
-$2,535.64
186.08K
Sep 28, 2012
Sep 24 - Sep 26
Form 4
-32.29%
-124.80K
$0.05
-$5,765.76
261.67K
Sep 10, 2012
Sep 6
Form 4
+1,064.91%
353.3K
$0.08
$30,278.78
386.47K
Sep 4, 2012
Aug 30
Form 4
-26.61%
-12.03K
$0.25
-$3,007.00
33.18K
Aug 10, 2012
Aug 7 - Aug 8
Form 4
∞
22.06M
—
$22,060.61
22.06M
Jul 23, 2012
Jul 18
Form 4
-30.67%
-2.00M
$0.01
-$16,335.00
4.52M
Jul 13, 2012
Jul 11 - Jul 12
Form 4
+56.06%
2.34M
$0.01
$26,935.56
6.52M
Jul 3, 2012
Jun 29
Form 4
-19.54%
-1.01M
$0.01
-$11,777.00
4.18M
Jun 13, 2012
Jun 12 - Jun 13
Form 4
-10.67%
-620.00K
$0.01
-$7,273.00
5.19M
Jun 12, 2012
Jun 11
Form 4
-0.23%
-13.50K
$0.02
-$209.25
5.81M
Jun 12, 2012
Jun 6
Form 4
+83.98%
2.66M
$0.02
$47,606.88
5.83M
Jun 4, 2012
Jun 1
Form 4
-2.53%
-82.05K
$0.02
-$1,501.46
3.17M
May 23, 2012
May 23
Form 4
+58.76%
1.2M
$0.02
$26,938.40
3.25M
May 2, 2012
May 2
Form 4
-39.57%
-1.34M
$0.02
-$30,820.00
2.05M
Apr 25, 2012
Apr 23
Form 4
+136.48%
1.95M
$0.03
$58,010.32
3.39M
Apr 4, 2012
Apr 2 - Apr 3
Form 4
-41.12%
-1.00M
$0.03
-$34,000.00
1.43M
Mar 12, 2012
Mar 8
Form 4
—
0
—
—
0
Mar 8, 2012
Jul 15
Form 4
+183.60%
1.57M
$0.04
$63,042.71
2.43M
Mar 7, 2012
Feb 29 - Mar 5
Form 4
+90.57%
407.57K
$0.55
$222,124.02
857.57K
Apr 15, 2010
Apr 8
Form 4
-10.00%
-49.99K
$1.20
-$59,734.46
450K
Mar 2, 2010
Feb 25
Form 4
-63.85%
-883.15K
$0.80
-$706,522.40
499.99K
Aug 14, 2009
Aug 11
Form 4
∞
1.38M
$0.80
$1,106,512.00
1.38M
Aug 7, 2009
Jul 29
Form 3
—
0
—
—
0
Jun 2, 2009
No matching records found

PharmaCyte Biotech, Inc. (PMCB) Snapshot price: $1.62

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Nov 22, 2023
Nov 20
Form 3
—
0
—
—
0
Sep 3, 2021
No matching records found